# A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )

> **NCT05380388** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Oxford** · enrollment: 36 (estimated)

## Conditions studied

- Plasmodium Vivax Infection
- Malaria Vaccine

## Interventions

- **BIOLOGICAL:** Malaria Vaccine
- **BIOLOGICAL:** HBV vaccine

## Key facts

- **NCT ID:** NCT05380388
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- Mahidol University

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05380388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05380388, "A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05380388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*